LAZARD ASSET MANAGEMENT LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$84,000
+42.4%
20,567
+22.9%
0.00%
Q4 2021$59,000
+126.9%
16,736
+133.9%
0.00%
Q3 2021$26,000
-58.1%
7,156
-52.9%
0.00%
Q1 2021$62,000
+12.7%
15,178
+9.1%
0.00%
Q4 2020$55,0000.0%13,913
-32.3%
0.00%
Q3 2020$55,000
-8.3%
20,562
-6.4%
0.00%
Q2 2020$60,000
+46.3%
21,959
+23.7%
0.00%
Q1 2020$41,000
-6.8%
17,746
+86.6%
0.00%
Q4 2019$44,000
+238.5%
9,511
+127.9%
0.00%
Q3 2019$13,0004,1740.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders